v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 16,856 $ 14,907
Restricted cash 958 957
Other current assets 2,706 1,768
Total current assets 20,520 17,632
Non-current assets    
Non-current restricted cash 161
Operating lease right-of-use assets 5,457 3,495
Property and equipment, net 5,045 3,902
In-process Research and development (“IPR&D”) asset 12,050
Total non-current assets 22,713 7,397
Total Assets 43,233 25,029
Current liabilities    
Trade account payables 1,882 1,381
Current portion of lease liabilities 1,130 666
Other account payables 5,255 3,344
Current portion of long-term debt 5,785
Total current liabilities 8,267 11,176
Non-current liabilities    
Contract liability 1,976
Long-term debt, net of current portion 5,402
Operating lease liabilities, net of current portion 8,454 3,239
Other liabilities 77 155
Private Placement Warrants 2,287
Total non-current liabilities 10,818 10,772
Commitments and Contingencies (Note 8)
Stockholders’ equity    
Preferred Stock, $0.0001 par value; Authorized - 1,000,000 shares as of December 31, 2024 and December 31, 2023. Issued and outstanding – 147,735 as of December 31, 2024. No shares issued and outstanding as of December 31, 2023. 18,645
Common stock, $0.0001 par value (“Common Stock”); Authorized - 750,000,000 shares as of December 31, 2024 and 120,000,000 shares as of December 31, 2023. Issued and outstanding – 18,176,661 and 4,723,380 as of December 31, 2024 and December 31, 2023, respectively. [1] 6 3
Additional paid in capital 186,194 166,048
Accumulated deficit (180,697) (162,970)
Total Stockholders’ equity 24,148 3,081
Total liabilities and stockholders’ equity $ 43,233 $ 25,029
[1] All share amounts have been retroactively adjusted to reflect a 1-for-10 reverse share split as discussed in Note 12A.

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL